KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Pension (2016 - 2025)

Abbott Laboratories (ABT) has disclosed Pension for 16 consecutive years, with $7.6 billion as the latest value for Q4 2025.

  • Quarterly Pension rose 12.17% to $7.6 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.6 billion through Dec 2025, up 12.17% year-over-year, with the annual reading at $7.6 billion for FY2025, 12.17% up from the prior year.
  • Pension hit $7.6 billion in Q4 2025 for Abbott Laboratories, up from $6.7 billion in the prior quarter.
  • In the past five years, Pension ranged from a high of $9.1 billion in Q2 2021 to a low of $6.6 billion in Q2 2024.
  • Historically, Pension has averaged $7.6 billion across 5 years, with a median of $7.2 billion in 2023.
  • Biggest five-year swings in Pension: dropped 16.69% in 2023 and later rose 12.17% in 2025.
  • Year by year, Pension stood at $8.8 billion in 2021, then decreased by 14.24% to $7.5 billion in 2022, then decreased by 7.64% to $6.9 billion in 2023, then fell by 3.11% to $6.7 billion in 2024, then grew by 12.17% to $7.6 billion in 2025.
  • Business Quant data shows Pension for ABT at $7.6 billion in Q4 2025, $6.7 billion in Q3 2025, and $6.8 billion in Q2 2025.